UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Ukrainian military losses updated on 1,730th day of war

Putin vows painful retaliation for Crimean Bridge attacks

Baku hosts Special Olympics badminton tournament

UN-Habitat representatives briefed on Great Return Programme

Three candidates nominated for FIFA presidential election

Khankendi Stadium opens with First League clash - Video

Khankendi stadium hosts first official match after renovation

President Aliyev arrives in Vietnam on official visit

Cyberattack using artificial intelligence targeted the EU

Trump says US will reassess Iran conflict after January 1

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla